Search research articles
Contact Us
Filters
Showing results (111-120 of 324) with videos related to
Page
of 33
Sort By:
Gastrointestinal Endoscopy
|
May 1, 1989
A randomized study of a coaxial fiber versus a naked fiber for endoscopic Nd:YAG laser therapy of esophageal and rectal tumors
S Naveau, T Poynard, O Zourabichvili, et al.
Revue Neurologique
|
February 1, 1997
[Sensory neuronopathy associated with chronic autoimmune hepatitis]
L Magy, G Bassez, B Chassande, et al.
Gastroenterologie Clinique Et Biologique
|
January 1, 1997
[Recurrent lower digestive hemorrhage in young adults: a surgical indication]
G Tordjman, B Bernard, J P Chigot, et al.
American Journal of Public Health
|
October 13, 2000
Estimating future hepatitis C morbidity, mortality, and costs in the United States
J B Wong, G M McQuillan, J G McHutchison, et al.
Gastroenterologie Clinique Et Biologique
|
December 1, 1988
[Sclerotherapy of esophageal varices using ethanol in combination with propranolol: clinical study of 30 patients]
T Poynard, A Aubert, S Naveau, et al.
The Cochrane Database of Systematic Reviews
|
July 22, 2005
Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B
M T Mellerup, K Krogsgaard, P Mathurin, et al.
Journal of Clinical Microbiology
|
June 8, 2006
Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection
V Avettand-Fenoel, D Thabut, C Katlama, et al.
Gastroenterologie Clinique Et Biologique
|
January 1, 1991
[Hepatotoxicity of moxisylyte chlorhydrate: a new case]
V Ratziu, T Poynard, H Sabah, et al.
The Cochrane Database of Systematic Reviews
|
June 22, 2002
Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B
M T Mellerup, K Krogsgaard, P Mathurin, et al.
Hepatology (Baltimore, Md.)
|
December 29, 1999
Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group
T Poynard, J McHutchison, Z Goodman, et al.
Page
of 33
Search research articles
Search
Showing results (111-120 of 324) with videos related to
Sort By:
Page
of 33
Gastrointestinal Endoscopy
|
May 1, 1989
A randomized study of a coaxial fiber versus a naked fiber for endoscopic Nd:YAG laser therapy of esophageal and rectal tumors
S Naveau, T Poynard, O Zourabichvili, et al.
Revue Neurologique
|
February 1, 1997
[Sensory neuronopathy associated with chronic autoimmune hepatitis]
L Magy, G Bassez, B Chassande, et al.
Gastroenterologie Clinique Et Biologique
|
January 1, 1997
[Recurrent lower digestive hemorrhage in young adults: a surgical indication]
G Tordjman, B Bernard, J P Chigot, et al.
American Journal of Public Health
|
October 13, 2000
Estimating future hepatitis C morbidity, mortality, and costs in the United States
J B Wong, G M McQuillan, J G McHutchison, et al.
Gastroenterologie Clinique Et Biologique
|
December 1, 1988
[Sclerotherapy of esophageal varices using ethanol in combination with propranolol: clinical study of 30 patients]
T Poynard, A Aubert, S Naveau, et al.
The Cochrane Database of Systematic Reviews
|
July 22, 2005
Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B
M T Mellerup, K Krogsgaard, P Mathurin, et al.
Journal of Clinical Microbiology
|
June 8, 2006
Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection
V Avettand-Fenoel, D Thabut, C Katlama, et al.
Gastroenterologie Clinique Et Biologique
|
January 1, 1991
[Hepatotoxicity of moxisylyte chlorhydrate: a new case]
V Ratziu, T Poynard, H Sabah, et al.
The Cochrane Database of Systematic Reviews
|
June 22, 2002
Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B
M T Mellerup, K Krogsgaard, P Mathurin, et al.
Hepatology (Baltimore, Md.)
|
December 29, 1999
Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group
T Poynard, J McHutchison, Z Goodman, et al.
Page
of 33